2025 - Introduced
Georgia H.B. 326
  • Prohibits practices that disadvantage or discourage the use of non-opioid drugs relative to opioids in state employees' health insurance and benefit plans.
2025 - Introduced
Oklahoma H.B.1416
  • Ensures that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to coverage relative to an opioid for the treatment or management of pain on the state preferred drug list.
2024 - Introduced
Tennessee H.B.37
  • Aligns group health insurance plans providing coverage for state employees with Medicaid non-opioid parity policy, ensuring reimbursement of all FDA-approved non-opioid drugs.